ATMI Invests in Sterile Fill and Connector Technology
ATMI has invested in sterile-connector and sterile-fill technology developed by Medical Instill Technologies.
ATMI, a provider of single-use bioprocess solutions, has invested in sterile connector and sterile fill technology developed by Medical Instill Technologies (Medinstill), a provider of transfer and packaging solutions for high purity fluids at unmatched safety levels.
The investments focus on the INTACT family of products developed by Medinstill. These technologies will be deployed in sterile filling, sterile multiple-dose dispensing, sterile transfer, and packaging sterilization solutions.
In other news, ATMI has introduced a line of pyrogen-free vials in collaboration with Disposable Lab, a Bordeaux, France contract manufacturing organization
Source: ATMI
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
